CStone Pharmaceuticals (HKSE:02616) Change In Inventory : HK$32.2 Mil (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Change In Inventory?

CStone Pharmaceuticals's change in inventory for the quarter that ended in Jun. 2023 was HK$0.0 Mil. It means CStone Pharmaceuticals's inventory stayed the same from Dec. 2022 to Jun. 2023 .

CStone Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2023 was HK$-104.4 Mil. It means CStone Pharmaceuticals's inventory increased by HK$104.4 Mil from Dec. 2022 to Dec. 2023 .

CStone Pharmaceuticals's Total Inventories for the quarter that ended in Jun. 2023 was HK$0.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. CStone Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2023 was 19.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. CStone Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2023 was 9.54.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. CStone Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.04.

CStone Pharmaceuticals Change In Inventory Historical Data

The historical data trend for CStone Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Change In Inventory Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-105.52

33.97

-104.41

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial									-68.61	1.87	32.19	-	-

CStone Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$32.2 Mil.

CStone Pharmaceuticals (HKSE:02616) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

CStone Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	12.389	/	118.169	*	365 / 2
	=	19.13

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

CStone Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	118.169	/	12.389
	=	9.54

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

CStone Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	12.389	/	285.995
	=	0.04

CStone Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (HKSE:02616) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

CSPHF:USA PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

Executives

Su Zhou Gong Ye Yuan Qu Zheng Ze Yuan Shi Chuang Ye Tou Zi Qi Ye You Xian He Huo	2101 Beneficial owner
Su Zhou Gong Ye Yuan Qu Zheng Ze Ji Ming Gu Quan Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Jian Kang Chuang Ye Tou Zi Guan Li Zhong Xin You Xian He Huo	2501 Other
Su Zhou Gong Ye Yuan Qu Yuan He Yuan Dian Chuang Ye Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Guan Wei Hui	2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Jing Ji Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Yuan He Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Fei Jianjiang	2201 Interest of corporation controlled by you
Wuxi Healthcare Ventures Ii, L.p.	2101 Beneficial owner
Wuxi Healthcare Management, Llc	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Gic Private Limited	2102 Investment manager
Jiang Frank Ningjun	2307 Founder of a discretionary trust who can infl
Graceful Beauty Limited	2101 Beneficial owner
Boyu Capital Holdings Ltd.	2201 Interest of corporation controlled by you

CStone Pharmaceuticals (HKSE:02616) Headlines

No Headlines